speb/financial-data huggingface dataset:
Financial ratios for NCX.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -886011.1888111888
Net income: -746151.048951049
Capital expenditures: 0
Operating cash flow: -902738.4615384616
Depreciation & amortization: 8555.244755244756
Net tangible assets: 11125854.545454547
Owner earnings: -737595.8041958043
Return on net tangible assets (%): -6.6295654071547085
Buffett classification: The Gruesome
Stock price: 0.5174825174825175
Shares outstanding: 332057717
Book value: 11125854.545454545
P/B ratio: 15.444572157637992
Market cap (USD): 171834063.34265736
Debt to equity: 0.010025096210100183
Current ratio: 3.0293465320553796
Quick ratio: 3.0293465320553796
Free cash flow (dilution-adjusted): -1000901.3986013987
Buyback yield (%): 0
Retained earnings: -29815070.62937063
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.913754667459169
Rule of 40 score: 0
Financial ratios for NCX.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -2731384.6715328465
Net income: -2111467.883211679
Capital expenditures: 0
Operating cash flow: -2157334.306569343
Depreciation & amortization: 8929.92700729927
Net tangible assets: 10024207.299270073
Owner earnings: -2102537.9562043794
Return on net tangible assets (%): -20.974605706303368
Buffett classification: The Gruesome
Stock price: 0.7956204379562044
Shares outstanding: 332057717
Book value: 10024207.299270073
P/B ratio: 26.355391338077663
Market cap (USD): 264191906.22627738
Debt to equity: 0.010787317474691192
Current ratio: 2.449666062684377
Quick ratio: 2.449666062684377
Free cash flow (dilution-adjusted): -2530555.4744525547
Buyback yield (%): 0
Retained earnings: -33232308.02919708
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.0729841065105
Rule of 40 score: 0
Financial ratios for NCX.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2842833.8129496407
Net income: -2045995.6834532376
Capital expenditures: 0
Operating cash flow: -2328400.7194244605
Depreciation & amortization: 10235.971223021583
Net tangible assets: 32648828.05755396
Owner earnings: -2035759.712230216
Return on net tangible assets (%): -6.235322470508103
Buffett classification: The Gruesome
Stock price: 1.0359712230215827
Shares outstanding: 332057717
Book value: 32648828.057553962
P/B ratio: 10.536434526465424
Market cap (USD): 344002239.1942446
Debt to equity: 0.0030084920914785554
Current ratio: 7.681152317107375
Quick ratio: 7.681152317107375
Free cash flow (dilution-adjusted): -2769467.625899281
Buyback yield (%): 0
Retained earnings: -34800141.00719424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.692537756016524
Rule of 40 score: 0
Financial ratios for NCX.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -5959837.226277372
Net income: -4875925.547445255
Capital expenditures: 49902.91970802919
Operating cash flow: -5392672.262773722
Depreciation & amortization: 46502.189781021894
Net tangible assets: 28735660.583941605
Owner earnings: -4879326.277372262
Return on net tangible assets (%): -16.980038663523832
Buffett classification: The Gruesome
Stock price: 1.9124087591240875
Shares outstanding: 332057717
Book value: 28735660.5839416
P/B ratio: 22.099025170154686
Market cap (USD): 635030086.5255474
Debt to equity: 0.01103661858132733
Current ratio: 6.584517756034681
Quick ratio: 6.584517756034681
Free cash flow (dilution-adjusted): -5646926.277372262
Buyback yield (%): 0
Retained earnings: -40184097.810218975
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.644214580995474
Rule of 40 score: 0
Financial ratios for NCX.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -12500371.532846713
Net income: -9842086.861313868
Capital expenditures: 224565.69343065692
Operating cash flow: -10854672.99270073
Depreciation & amortization: 74747.44525547445
Net tangible assets: 28735660.583941605
Owner earnings: -9991905.10948905
Return on net tangible assets (%): -34.77179541532044
Buffett classification: The Gruesome
Stock price: 1.9124087591240875
Shares outstanding: 332057717
Book value: 28735660.5839416
P/B ratio: 22.099025170154686
Market cap (USD): 635030086.5255474
Debt to equity: 0.01103661858132733
Current ratio: 6.584517756034681
Quick ratio: 6.584517756034681
Free cash flow (dilution-adjusted): -12032116.05839416
Buyback yield (%): 0
Retained earnings: -40184097.810218975
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.299899387930814
Rule of 40 score: 0
Financial ratios for NMAX — quarterly report dated 2025-03-31
Total revenue: 45301707
Gross profit: 19462136
Operating income: -11572780
Net income: -17232525
Capital expenditures: 40786
Operating cash flow: -15725959
Depreciation & amortization: 1540440
Net tangible assets: 177380357
Owner earnings: -15732871
Return on net tangible assets (%): -8.869567784216377
Buffett classification: The Gruesome
Stock price: 83.51
Shares outstanding: 89921348
Book value: 177380357
P/B ratio: 42.33462993582768
Market cap (USD): 7509331771.4800005
Debt to equity: 0.04083529384259837
Current ratio: 3.5670914213569027
Quick ratio: 3.5404493862978925
Interest coverage ratio: -1911.2766308835673
COGS to revenue (%): 57.038846240385595
SG&A to revenue (%): 66.88057251352582
Free cash flow (dilution-adjusted): -17343854
Buyback yield (%): 0.08430547740671043
Retained earnings: -245608178
Inventory turnover: 13.722350915652873
Receivables turnover: 1.5662137552293751
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.576477958222997
FCF margin (%): -38.28521075375813
Rule of 40 score: -38.28521075375813
Financial ratios for NMAX — quarterly report dated 2025-06-30
Total revenue: 46439744
Gross profit: 17641761
Operating income: -76405449
Net income: -75175622
Capital expenditures: 648674
Operating cash flow: -23221904
Depreciation & amortization: 1459405
Net tangible assets: 106852896
Owner earnings: -74364891
Return on net tangible assets (%): -69.59557839218509
Buffett classification: The Gruesome
Stock price: 15.13
Shares outstanding: 89921348
Book value: 106852896
P/B ratio: 12.732551443809253
Market cap (USD): 1360509995.24
Debt to equity: 0.05871475865286796
Current ratio: 2.5016194607613866
Quick ratio: 2.48432044582626
Interest coverage ratio: -10247.511936695279
COGS to revenue (%): 62.011502475121304
SG&A to revenue (%): 200.93267525333474
Free cash flow (dilution-adjusted): -27288263
Buyback yield (%): 0
Retained earnings: -320783799
Inventory turnover: 17.549558427059413
Receivables turnover: 1.5713915825191536
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -46.32327048018994
FCF margin (%): -58.7605801616822
Revenue growth (%): 2.512128295739496
Rule of 40 score: -56.248451865942705
Financial ratios for NMAX — quarterly report dated 2025-09-30
Total revenue: 45272696
Gross profit: 15960736
Operating income: -7198559
Net income: -4115406
Capital expenditures: 1093537
Operating cash flow: -68134154
Depreciation & amortization: 1614760
Net tangible assets: 105961062
Owner earnings: -3594183
Return on net tangible assets (%): -3.391984689621174
Buffett classification: The Gruesome
Stock price: 12.4
Shares outstanding: 89921348
Book value: 105961062
P/B ratio: 10.522966589368462
Market cap (USD): 1115024715.2
Debt to equity: 0.04914267469308679
Current ratio: 2.737727009188069
Quick ratio: 2.712116495806722
Interest coverage ratio: -1319.625847846013
COGS to revenue (%): 64.74533789637799
SG&A to revenue (%): 49.630300347034776
Free cash flow (dilution-adjusted): -72775030
Buyback yield (%): 0
Retained earnings: -324899206
Inventory turnover: 16.299816493354836
Receivables turnover: 1.4783685308533663
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.413211358733723
FCF margin (%): -160.74816927182778
Revenue growth (%): -2.5130371089039594
Rule of 40 score: -163.26120638073175
Financial ratios for NMAX — annual report dated 2025-12-31
Total revenue: 189254921
Gross profit: 74422373
Operating income: -99854569
Net income: -99495119
Capital expenditures: 2650515
Operating cash flow: -104454878
Depreciation & amortization: 6327229
Net tangible assets: 106048552
Owner earnings: -95818405
Return on net tangible assets (%): -90.35333646045444
Buffett classification: The Gruesome
Stock price: 7.73
Shares outstanding: 89921348
Book value: 106048552
P/B ratio: 6.554469692712071
Market cap (USD): 695092020.0400001
Debt to equity: 0.08821493385407092
Current ratio: 2.4048970495211854
Quick ratio: 2.3799553212181617
Interest coverage ratio: -4310.207148098589
COGS to revenue (%): 60.67612265680532
SG&A to revenue (%): 90.6116819017879
Free cash flow (dilution-adjusted): -119061275
Buyback yield (%): 0
Retained earnings: -327870772
Inventory turnover: 56.646784084989505
Receivables turnover: 5.663867158011201
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -62.973142682211744
FCF margin (%): -62.91053060649345
Revenue growth (%): 10.664743342972464
Rule of 40 score: -52.24578726352099
Financial ratios for NMAX — quarterly report dated 2025-12-31
Total revenue: 52240774
Gross profit: 21357738
Operating income: -4677781
Net income: -2971567
Capital expenditures: 867518
Operating cash flow: 2627139
Depreciation & amortization: 1712624
Net tangible assets: 106048552
Owner earnings: -2126461
Return on net tangible assets (%): -2.0051768363607643
Buffett classification: The Gruesome
Stock price: 7.73
Shares outstanding: 89921348
Book value: 106048552
P/B ratio: 6.554469692712071
Market cap (USD): 695092020.0400001
Debt to equity: 0.08821493385407092
Current ratio: 2.4048970495211854
Quick ratio: 2.3799553212181617
Interest coverage ratio: -1113.492263746727
COGS to revenue (%): 59.11672748187077
SG&A to revenue (%): 48.63524610106275
Free cash flow (dilution-adjusted): -1654128
Buyback yield (%): 0
Retained earnings: -327870772
Inventory turnover: 15.234571579661873
Receivables turnover: 1.5634193425685636
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.9500359703033636
FCF margin (%): -3.1663543116723347
Revenue growth (%): 15.391347579565394
Rule of 40 score: 12.22499326789306
Financial ratios for NTI.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.03759398496240601
Shares outstanding: 1322741687
Market cap (USD): 49727131.09022556
Buyback yield (%): 0.6705451326718487
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTI.AX — annual report dated 2022-06-30
Total revenue: 2640.344827586207
Gross profit: -20841.724137931036
Operating income: -2734584.4827586208
Net income: -2318786.896551724
Capital expenditures: 2210.344827586207
Depreciation & amortization: 405.51724137931035
Net tangible assets: 986200.6896551724
Owner earnings: -2320591.724137931
Return on net tangible assets (%): -235.30623619309492
Buffett classification: The Gruesome
Stock price: 0.048275862068965524
Shares outstanding: 1322741687
Book value: 986200.6896551724
P/B ratio: 64.7500005874163
Market cap (USD): 63856495.234482765
Debt to equity: 0
Current ratio: 3.4071199703194037
Quick ratio: 3.394974535397484
Interest coverage ratio: -2896.382395909423
COGS to revenue (%): 889.3561447041924
R&D to revenue (%): 67341.07352749119
SG&A to revenue (%): 16593.261068303513
Free cash flow (dilution-adjusted): -2040233.7931034483
Buyback yield (%): 0
Retained earnings: -19790417.24137931
Inventory turnover: 4.727714523743405
Receivables turnover: 0.03848396208397415
Capitalized R&D asset: 1778036.551724138
ROCI (R&D-adjusted, %): -56.04536247533355
FCF margin (%): -77271.4901397414
Rule of 40 score: -77271.4901397414
Financial ratios for NTI.AX — annual report dated 2023-06-30
Total revenue: 3946.3576158940396
Gross profit: 3946.3576158940396
Operating income: -5992762.913907285
Net income: -5160224.503311258
Capital expenditures: 0
Depreciation & amortization: 1154.9668874172185
Net tangible assets: 2623816.5562913907
Owner earnings: -5159069.536423841
Return on net tangible assets (%): -196.6246277413494
Buffett classification: The Gruesome
Stock price: 0.026490066225165563
Shares outstanding: 1322741687
Book value: 2623816.5562913907
P/B ratio: 13.354407267306634
Market cap (USD): 35039514.88741722
Debt to equity: 0
Current ratio: 3.940966702725659
Quick ratio: 3.9351895918453716
COGS to revenue (%): 0
R&D to revenue (%): 108285.97080046989
SG&A to revenue (%): 27356.972646417187
Free cash flow (dilution-adjusted): -4183413.9072847683
Buyback yield (%): 0
Retained earnings: -24124532.450331125
Inventory turnover: 0
Receivables turnover: 0.023136176920508456
Capitalized R&D asset: 5464636.145284312
ROCI (R&D-adjusted, %): -46.195988263630774
Rosenberg metric: 0.013941266690939738
FCF margin (%): -106006.9642557476
Revenue growth (%): 49.463720596744345
Rule of 40 score: -105957.50053515086
Financial ratios for NTI.AX — annual report dated 2024-06-30
Total revenue: 1308.6666666666667
Gross profit: -3911.3333333333335
Operating income: -5601848
Net income: -3379500.6666666665
Capital expenditures: 0
Depreciation & amortization: 388.6666666666667
Net tangible assets: 7932458
Owner earnings: -3379112
Return on net tangible assets (%): -42.598548898714625
Buffett classification: The Gruesome
Stock price: 0.04666666666666667
Shares outstanding: 1322741687
Book value: 7932458
P/B ratio: 7.781692054762009
Market cap (USD): 61727945.39333334
Debt to equity: 0
Current ratio: 38.80882049196216
Quick ratio: 38.80882049196216
COGS to revenue (%): 398.8792664289353
R&D to revenue (%): 267319.8675496689
SG&A to revenue (%): 121156.03667855324
Free cash flow (dilution-adjusted): -3063527.3333333335
Buyback yield (%): 0
Retained earnings: -27704863.333333332
Receivables turnover: 0.006171927320289386
Capitalized R&D asset: 6948223.671340489
ROCI (R&D-adjusted, %): -35.52767397275769
Rosenberg metric: -0.0018387653491789536
FCF margin (%): -234095.31329597553
Revenue growth (%): -66.83861945516585
Rule of 40 score: -234162.1519154307
Financial ratios for NWRN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7802197802197803
Shares outstanding: 20805797
Market cap (USD): 37038891.36263736
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NWRN.SW — annual report dated 2022-12-31
Total revenue: 6482978.723404256
Operating income: -14151063.829787236
Net income: -18609574.468085106
Capital expenditures: 19148.936170212768
Operating cash flow: -11800000
Depreciation & amortization: 214893.61702127662
Net tangible assets: -14925531.914893618
Owner earnings: -18413829.78723404
Buffett classification: The Gruesome
Stock price: 1.684782608695652
Shares outstanding: 20805797
Book value: -14925531.91489362
Market cap (USD): 35053244.94565217
Debt to equity: -3.254597291518175
Current ratio: 5.652251537393375
Quick ratio: 5.652251537393375
Interest coverage ratio: -3.370154547757791
COGS to revenue (%): 0
R&D to revenue (%): 196.99704627502464
SG&A to revenue (%): 59.353462422054484
Free cash flow (dilution-adjusted): -12329787.234042553
Buyback yield (%): 0
Retained earnings: -24260638.297872342
Receivables turnover: 3.1347736625514404
Capitalized R&D asset: 12771276.595744682
ROCI (R&D-adjusted, %): -11.999063988465922
FCF margin (%): -190.18706924844108
Rule of 40 score: -190.18706924844108
Financial ratios for NWRN.SW — annual report dated 2023-12-31
Total revenue: 10063333.333333334
Operating income: -12921111.11111111
Net income: -18026666.666666668
Capital expenditures: 12222.222222222223
Operating cash flow: -11266666.666666666
Depreciation & amortization: 223333.3333333333
Net tangible assets: -33231111.111111112
Owner earnings: -17815555.55555556
Buffett classification: The Gruesome
Stock price: 5.892857142857143
Shares outstanding: 20805797
Book value: -33231111.111111112
Market cap (USD): 122605589.46428572
Debt to equity: -1.6187976461147517
Current ratio: 0.6793887851759662
Quick ratio: 0.6793887851759662
Interest coverage ratio: -2.7900671785028788
COGS to revenue (%): 0
R&D to revenue (%): 145.21364690294797
SG&A to revenue (%): 44.84928784365683
Free cash flow (dilution-adjusted): -11497777.777777776
Buyback yield (%): 0
Retained earnings: -23773333.333333332
Receivables turnover: 4.4792284866468846
Capitalized R&D asset: 23170088.65248227
ROCI (R&D-adjusted, %): -37.61227993551162
FCF margin (%): -114.25416804681458
Revenue growth (%): 55.226999234219456
Rule of 40 score: -59.02716881259513
Financial ratios for NWRN.SW — annual report dated 2024-12-31
Total revenue: 53531250
Operating income: 27263541.666666668
Net income: 16503125
Capital expenditures: 13541.666666666668
Operating cash flow: -18347916.666666668
Depreciation & amortization: 200000
Net tangible assets: 1518750
Owner earnings: 16689583.333333334
Return on net tangible assets (%): 1098.9026063100137
Capex to operating income (%): 0.049669506743590726
Buffett classification: The Great
Stock price: 9.944444444444443
P/E ratio: 12.537146291316878
Shares outstanding: 20805797
Book value: 1518750
P/B ratio: 136.23183037951532
Market cap (USD): 206902092.38888887
Debt to equity: 34.61522633744856
Current ratio: 2.5995065089764315
Quick ratio: 2.5995065089764315
Effective tax rate (%): 25.94652706366271
Interest coverage ratio: 6.012634964392373
COGS to revenue (%): 0
R&D to revenue (%): 26.54602062658105
SG&A to revenue (%): 14.588441330998247
Free cash flow (dilution-adjusted): -18628125.000000004
Buyback yield (%): 0
Retained earnings: 11130208.333333334
Receivables turnover: 1.2201723769499253
Capitalized R&D asset: 28215871.276595745
ROCI (R&D-adjusted, %): 39.27232384471716
FCF margin (%): -34.798598949211915
Revenue growth (%): 431.94352434580986
Rule of 40 score: 397.14492539659796
Financial ratios for NWRN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1518750
Buffett classification: The Gruesome
Stock price: 9.944444444444443
Shares outstanding: 20805797
Book value: 1518750
P/B ratio: 136.23183037951532
Market cap (USD): 206902092.38888887
Debt to equity: 34.61522633744856
Current ratio: 2.5995065089764315
Quick ratio: 2.5995065089764315
Buyback yield (%): 0
Retained earnings: 11130208.333333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NWRN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1860000
Buffett classification: The Gruesome
Stock price: 8.325
Shares outstanding: 20805797
Book value: 1861176.470588237
P/B ratio: 93.06385652417815
Market cap (USD): 173208260.02499998
Debt to equity: 33.22756005056887
Current ratio: 1.508644993887378
Quick ratio: 1.508644993887378
Buyback yield (%): 0
Retained earnings: -6048235.294117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPT.AX — annual report dated 2021-06-30
Gross profit: -270893.23308270675
Capital expenditures: 0
Operating cash flow: -34245238.34586466
Depreciation & amortization: 80201.50375939849
Buffett classification: The Gruesome
Stock price: 0.9473684210526315
Shares outstanding: 1367978173
Market cap (USD): 1295979321.7894735
Free cash flow (dilution-adjusted): -37175793.233082704
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPT.AX — annual report dated 2022-06-30
Total revenue: 62540
Gross profit: -28348.275862068967
Operating income: -66577905.51724138
Net income: -64011980
Capital expenditures: 11662.068965517241
Operating cash flow: -49196518.62068966
Depreciation & amortization: 54056.551724137935
Net tangible assets: 33087685.51724138
Owner earnings: -63969585.51724138
Return on net tangible assets (%): -193.33351522549987
Buffett classification: The Gruesome
Stock price: 0.7172413793103449
Shares outstanding: 1367978173
Book value: 33087685.51724138
P/B ratio: 29.653647159989347
Market cap (USD): 981170551.6689657
Debt to equity: 0
Current ratio: 4.975081344404749
Quick ratio: 4.975081344404749
COGS to revenue (%): 145.32823131127114
R&D to revenue (%): 89813.7942061908
SG&A to revenue (%): 14991.357806865673
Free cash flow (dilution-adjusted): -52829954.48275863
Buyback yield (%): 0
Retained earnings: -149614726.20689654
Receivables turnover: 0.01383004974565934
Capitalized R&D asset: 56169546.89655173
ROCI (R&D-adjusted, %): -32.63068424291832
FCF margin (%): -84473.86389951811
Rule of 40 score: -84473.86389951811
Financial ratios for OPT.AX — annual report dated 2023-06-30
Total revenue: 71523.17880794701
Gross profit: -38688.741721854305
Operating income: -99354304.63576159
Net income: -94384768.21192053
Capital expenditures: 14569.53642384106
Operating cash flow: -79873098.67549668
Depreciation & amortization: 67037.74834437086
Net tangible assets: -3876276.821192053
Owner earnings: -94332300
Buffett classification: The Gruesome
Stock price: 0.3443708609271523
Shares outstanding: 1367978173
Book value: -3876276.821192056
Market cap (USD): 471091821.16556287
Debt to equity: -14.665829571559232
Current ratio: 5.249330043650737
Quick ratio: 5.249330043650737
Interest coverage ratio: -11.144332194324766
COGS to revenue (%): 154.46851851851852
R&D to revenue (%): 119285.1851851852
SG&A to revenue (%): 11831.481481481482
Free cash flow (dilution-adjusted): -83751447.6821192
Buyback yield (%): 0
Retained earnings: -238054594.70198676
Receivables turnover: 0.016456104712022735
Capitalized R&D asset: 122950152.71208039
ROCI (R&D-adjusted, %): -34.799655455672394
Rosenberg metric: -0.00018409380938802167
FCF margin (%): -117096.93148148149
Revenue growth (%): 14.363893201066539
Rule of 40 score: -117082.56758828042
Financial ratios for OPT.AX — annual report dated 2024-06-30
Total revenue: 83333.33333333333
Operating income: -127894666.66666667
Net income: -146828000
Capital expenditures: 22000
Operating cash flow: -107343569.33333333
Depreciation & amortization: 68683.33333333333
Net tangible assets: -50540000
Owner earnings: -146781316.66666666
Buffett classification: The Gruesome
Stock price: 0.2333333333333333
Shares outstanding: 1367978173
Book value: -50539999.999999985
Market cap (USD): 319194907.0333333
Debt to equity: -1.8684474343754127
Current ratio: 2.9379751775817655
Quick ratio: 2.9379751775817655
Interest coverage ratio: -6.339160030400159
COGS to revenue (%): 0
R&D to revenue (%): 141060.80000000002
SG&A to revenue (%): 10213.6
Free cash flow (dilution-adjusted): -110755075.33333333
Buyback yield (%): 0
Retained earnings: -386469333.3333333
Receivables turnover: 0.010571718538565629
Capitalized R&D asset: 193248709.85776055
ROCI (R&D-adjusted, %): -34.98099709950618
FCF margin (%): -132906.0904
Revenue growth (%): 16.51234567901235
Rule of 40 score: -132889.57805432097
Financial ratios for OPT.AX — quarterly report dated 2024-09-30
Capital expenditures: 7586.206896551725
Buffett classification: The Gruesome
Stock price: 0.5310344827586208
Shares outstanding: 1367978173
Market cap (USD): 726443581.524138
Free cash flow (dilution-adjusted): -28411724.137931034
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPT.AX — quarterly report dated 2024-12-31
Capital expenditures: 1242.2360248447205
Net tangible assets: -104785714.28571428
Buffett classification: The Gruesome
Stock price: 0.5031055900621118
Shares outstanding: 1367978173
Book value: -104785714.28571427
Market cap (USD): 688237465.9192545
Debt to equity: -0.9320826294419253
Current ratio: 1.570885151558089
Quick ratio: 1.570885151558089
Free cash flow (dilution-adjusted): -19492546.58385093
Buyback yield (%): 0
Retained earnings: -442001242.2360248
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPT.AX — annual report dated 2025-06-30
Total revenue: 16339.86928104575
Operating income: -99550326.79738562
Net income: -106399346.40522875
Capital expenditures: 8496.73202614379
Depreciation & amortization: 59477.124183006534
Net tangible assets: -131417647.05882353
Owner earnings: -106348366.0130719
Buffett classification: The Gruesome
Stock price: 0.39215686274509803
Shares outstanding: 1367978173
Book value: -131417647.05882353
Market cap (USD): 536462028.627451
Debt to equity: 0
Current ratio: 0.22026385592628786
Quick ratio: 0.22026385592628786
Interest coverage ratio: -3.2785586671545732
COGS to revenue (%): 0
R&D to revenue (%): 507328.00000000006
SG&A to revenue (%): 82148
Free cash flow (dilution-adjusted): -103697385.62091503
Buyback yield (%): 0
Retained earnings: -485290849.67320263
Receivables turnover: 0.0032868787799105966
Capitalized R&D asset: 189810142.26896942
ROCI (R&D-adjusted, %): -191.64833773569893
FCF margin (%): -634628
Revenue growth (%): -80.3921568627451
Rule of 40 score: -634708.3921568628
Financial ratios for PGHL.NS — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 63.926235024902404
Shares outstanding: 16599382
Market cap (USD): 1061135995.0001345
Buyback yield (%): 0
Retained earnings: 44110916.67788397
Capitalized R&D asset: 529007.9418495087
Rule of 40 score: 0
Financial ratios for PGHL.NS — annual report dated 2022-06-30
Total revenue: 138408111.5335868
Gross profit: 91879594.42332065
Operating income: 31408111.533586815
Net income: 24400506.970849175
Capital expenditures: 4806083.650190114
Operating cash flow: 21485424.588086184
Depreciation & amortization: 3432192.648922687
Net tangible assets: 78130544.99366286
Owner earnings: 23026615.969581746
Return on net tangible assets (%): 29.471976640441234
Capex to operating income (%): 15.302045922279166
Buffett classification: The Great
Stock price: 46.99645120405577
P/E ratio: 31.97114089114897
Shares outstanding: 16599382
Book value: 78135614.70215462
P/B ratio: 9.984077672572141
Market cap (USD): 780112046.1804817
Debt to equity: 0.0045905043066392
Current ratio: 2.621992238033635
Quick ratio: 2.1251832686502805
Effective tax rate (%): 24.016260804357266
Interest coverage ratio: 590.0238095238095
COGS to revenue (%): 33.616900479835905
R&D to revenue (%): 0.5997948793084503
SG&A to revenue (%): 15.240284238672578
Free cash flow (dilution-adjusted): 16247148.288973382
Buyback yield (%): 0
Retained earnings: 30046894.803548794
Inventory turnover: 3.1864421491190003
Receivables turnover: 13.087727708533077
Capitalized R&D asset: 1184600.0865651532
ROCI (R&D-adjusted, %): 37.679988067766
FCF margin (%): 11.738581004358814
Rule of 40 score: 11.738581004358814
Financial ratios for PGHL.NS — annual report dated 2023-06-30
Total revenue: 146912768.03118908
Gross profit: 99138645.22417155
Operating income: 36044103.31384016
Net income: 27956871.34502924
Capital expenditures: 5175438.596491228
Operating cash flow: 28752436.64717349
Depreciation & amortization: 3423489.278752437
Net tangible assets: 91368177.38791423
Owner earnings: 26204922.027290445
Return on net tangible assets (%): 28.68057870524701
Capex to operating income (%): 14.35862768294744
Buffett classification: The Great
Stock price: 57.341983430799225
P/E ratio: 34.04678141049375
Shares outstanding: 16599382
Book value: 91482699.80506822
P/B ratio: 10.40460644071169
Market cap (USD): 951841487.6055069
Debt to equity: 0.015981035837472866
Current ratio: 2.6196117143797304
Quick ratio: 2.175584073708457
Effective tax rate (%): 26.966900063653725
Interest coverage ratio: 384.22077922077926
COGS to revenue (%): 32.51870034664057
R&D to revenue (%): 0.47352097258388204
SG&A to revenue (%): 10.332874463038829
Free cash flow (dilution-adjusted): 23508771.92982456
Buyback yield (%): 0
Retained earnings: 45188840.15594542
Inventory turnover: 2.905958203646065
Receivables turnover: 10.421398323394694
Capitalized R&D asset: 1426445.781743935
ROCI (R&D-adjusted, %): 36.580791606054696
Rosenberg metric: 8.744108521941005
FCF margin (%): 16.001857595409085
Revenue growth (%): 6.144622886165528
Rule of 40 score: 22.146480481574613
Financial ratios for PGHL.NS — annual report dated 2024-06-30
Total revenue: 135349310.9646495
Gross profit: 92270820.85080886
Operating income: 33446375.074895147
Net income: 24083882.564409826
Capital expenditures: 2603954.463750749
Operating cash flow: 27356500.89874176
Depreciation & amortization: 3283403.2354703415
Net tangible assets: 64383463.15158778
Owner earnings: 24763331.33612942
Return on net tangible assets (%): 38.462254318046455
Capex to operating income (%): 7.78546092938268
Buffett classification: The Great
Stock price: 56.798801677651284
P/E ratio: 39.1475503863668
Shares outstanding: 16599382
Book value: 64498502.09706411
P/B ratio: 14.617781429570451
Market cap (USD): 942825006.1895745
Debt to equity: 0.017761593341260404
Current ratio: 2.39468274633411
Quick ratio: 1.8962587364670414
Effective tax rate (%): 26.46714473876774
Interest coverage ratio: 387.6527777777778
COGS to revenue (%): 31.82763902292185
R&D to revenue (%): 0.34174716022275536
SG&A to revenue (%): 9.298001753003566
Free cash flow (dilution-adjusted): 24669862.192929897
Buyback yield (%): 0
Retained earnings: 18881965.24865189
Inventory turnover: 3.2947484190266705
Receivables turnover: 13.23672799718739
Capitalized R&D asset: 1202600.853807227
ROCI (R&D-adjusted, %): 47.38612536385899
Rosenberg metric: -9.872347190290887
FCF margin (%): 18.226810330326074
Revenue growth (%): -7.870968072757776
Rule of 40 score: 10.355842257568298
Financial ratios for PGHL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 60.825250836120404
Shares outstanding: 16599382
Market cap (USD): 1009661573.8745819
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PGHL.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 71059564.05175428
Buffett classification: The Gruesome
Stock price: 57.97330691222753
Shares outstanding: 16599382
Book value: 71157477.56148735
P/B ratio: 13.523822094561478
Market cap (USD): 962321067.2393053
Debt to equity: 0.013563542246830259
Current ratio: 2.7850582029829027
Quick ratio: 2.244952710076391
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PGHL.NS — quarterly report dated 2025-03-31
Total revenue: 36356090.717792846
Gross profit: 24815291.091886833
Operating income: 8832125.321487023
Net income: 7152209.492635024
Capital expenditures: 377601.1222819733
Operating cash flow: 5754033.200841711
Depreciation & amortization: 627776.4788403086
Net tangible assets: 62689969.60486322
Owner earnings: 7402384.849193359
Return on net tangible assets (%): 11.807925407925406
Capex to operating income (%): 4.275314361350099
Buffett classification: The Great
Stock price: 57.89298634613141
P/E ratio: 33.5905917070031
Shares outstanding: 16599382
Book value: 62772971.709141925
P/B ratio: 15.30894219781324
Market cap (USD): 960987795.4802195
Debt to equity: 0.014191001191895111
Current ratio: 2.4448005201802054
Quick ratio: 1.9368352607867727
Effective tax rate (%): 22.093467464663185
Interest coverage ratio: 581.1538461538462
COGS to revenue (%): 31.743785973825524
Free cash flow (dilution-adjusted): 5330839.373392564
Buyback yield (%): 0
Inventory turnover: 0.9026241199597695
Receivables turnover: 2.1388583218707016
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.05083867401406
FCF margin (%): 14.662850895527185
Rule of 40 score: 14.662850895527185
Financial ratios for PGHL.NS — quarterly report dated 2025-06-30
Total revenue: 39637257.196349174
Gross profit: 28639129.41727124
Operating income: 9934472.267727593
Net income: 7743973.788907092
Capital expenditures: 0
Depreciation & amortization: 636555.1135033935
Owner earnings: 8380528.902410486
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 66.32775567516967
P/E ratio: 73.9115337697986
Shares outstanding: 16599382
Market cap (USD): 1100999753.6548092
Effective tax rate (%): 25.481364711181172
Interest coverage ratio: 707.5
COGS to revenue (%): 27.74694455924898
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 9.025080567725915
Rule of 40 score: 9.025080567725915
Financial ratios for PGHL.NS — quarterly report dated 2025-09-30
Total revenue: 36631341.60090192
Gross profit: 28919954.904171363
Operating income: 12873731.679819616
Net income: 9981961.66854566
Capital expenditures: 0
Depreciation & amortization: 685456.595264938
Net tangible assets: 69808342.72829764
Owner earnings: 10667418.263810597
Return on net tangible assets (%): 15.281007751937983
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 69.03540022547914
P/E ratio: 46.0623162283477
Shares outstanding: 16599382
Book value: 69868094.70124014
P/B ratio: 16.401549015551932
Market cap (USD): 1145944979.8656144
Debt to equity: 0.010004356735997935
Current ratio: 2.873207784619533
Quick ratio: 2.300912400557328
Effective tax rate (%): 25.609141320786428
Interest coverage ratio: 951.5833333333333
COGS to revenue (%): 21.051335713406377
Buyback yield (%): 0
Inventory turnover: 0.5371868373517632
Receivables turnover: 2.3632264164666523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.994835617865487
Revenue growth (%): -7.583561043482392
Rule of 40 score: -7.583561043482392
Financial ratios for PGHL.NS — quarterly report dated 2025-12-31
Total revenue: 41646429.76495489
Gross profit: 29412944.19070959
Operating income: 11647543.722847277
Net income: 8643199.28706695
Capital expenditures: 0
Depreciation & amortization: 657235.156511084
Owner earnings: 9300434.443578033
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 61.67516987857859
P/E ratio: 30.540830865448516
Shares outstanding: 16599382
Market cap (USD): 1023769704.7294197
Effective tax rate (%): 28.69876860871164
Interest coverage ratio: 1045.6
COGS to revenue (%): 29.37463221526775
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 13.69070294692535
Rule of 40 score: 13.69070294692535
Financial ratios for PGY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 119.16
Shares outstanding: 71808413
Market cap (USD): 8556690493.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PGY — annual report dated 2022-12-31
Total revenue: 685414000
Gross profit: 234330000
Operating income: -315019000
Net income: -292774000
Capital expenditures: 22406000
Operating cash flow: -40000000
Depreciation & amortization: 6294000
Net tangible assets: 553520000
Owner earnings: -308886000
Return on net tangible assets (%): -55.80394565688683
Buffett classification: The Gruesome
Stock price: 14.88
Shares outstanding: 71808413
Book value: 765423000
P/B ratio: 1.3959721427759555
Market cap (USD): 1068509185.44
Debt to equity: 0.2773081028398676
Current ratio: 3.2793513412176414
Quick ratio: 3.2793513412176414
COGS to revenue (%): 65.81190346272471
R&D to revenue (%): 22.020705734052704
SG&A to revenue (%): 58.12778846069675
Free cash flow (dilution-adjusted): -304095000
Buyback yield (%): 0
Retained earnings: -414199000
Receivables turnover: 8.787133663239404
Capitalized R&D asset: 150933000
ROCI (R&D-adjusted, %): -20.074738247593153
FCF margin (%): -44.36661638075674
Rule of 40 score: -44.36661638075674
Financial ratios for PGY — annual report dated 2023-12-31
Total revenue: 772814000
Gross profit: 263870000
Operating income: -63637000
Net income: -128438000
Capital expenditures: 20189000
Operating cash flow: -21659000
Depreciation & amortization: 19127000
Net tangible assets: 546226000
Owner earnings: -129500000
Return on net tangible assets (%): -23.70813546041382
Buffett classification: The Gruesome
Stock price: 16.56
Shares outstanding: 71808413
Book value: 665749000
P/B ratio: 1.786179655215404
Market cap (USD): 1189147319.28
Debt to equity: 0.6197290570470252
Current ratio: 4.049409409409409
Quick ratio: 4.049409409409409
COGS to revenue (%): 65.85594981457376
R&D to revenue (%): 9.624955034458486
SG&A to revenue (%): 32.753547425383076
Free cash flow (dilution-adjusted): -112903000
Buyback yield (%): 0
Retained earnings: -542637000
Receivables turnover: 8.840040264464323
Capitalized R&D asset: 175508110
ROCI (R&D-adjusted, %): -4.916832989025404
Rosenberg metric: 0.19571597993811823
FCF margin (%): -14.609336787377039
Revenue growth (%): 12.75141739153271
Rule of 40 score: -1.8579193958443287
Financial ratios for PGY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.57
Shares outstanding: 71808413
Market cap (USD): 759014925.41
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PGY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.29
Shares outstanding: 71808413
Market cap (USD): 667100156.77
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PGY — annual report dated 2024-12-31
Total revenue: 1004550000
Gross profit: 406898000
Operating income: 39142000
Net income: -401406000
Capital expenditures: 17737000
Operating cash flow: 47751000
Depreciation & amortization: 28753000
Net tangible assets: 290608000
Owner earnings: -390390000
Return on net tangible assets (%): -134.33559984584045
Capex to operating income (%): 45.31449593786726
Buffett classification: The Good
Stock price: 9.29
Shares outstanding: 71808413
Book value: 441546000
P/B ratio: 1.5108282189624636
Market cap (USD): 667100156.77
Debt to equity: 1.5418823859801696
Current ratio: 9.03539633329506
Quick ratio: 9.03539633329506
COGS to revenue (%): 59.49450002488676
R&D to revenue (%): 7.622417998108606
SG&A to revenue (%): 28.98661092031258
Free cash flow (dilution-adjusted): -36983000
Buyback yield (%): 0
Retained earnings: -944043000
Receivables turnover: 7.08672249225755
Capitalized R&D asset: 176215500
ROCI (R&D-adjusted, %): 1.128490763306095
Rosenberg metric: 1.922858717717758
FCF margin (%): -3.6815489522671845
Revenue growth (%): 29.98599921844066
Rule of 40 score: 26.304450266173475
Financial ratios for PGY — quarterly report dated 2025-03-31
Total revenue: 282704000
Gross profit: 115621000
Operating income: 40400000
Net income: 7893000
Capital expenditures: 3776000
Operating cash flow: 34427000
Depreciation & amortization: 7722000
Net tangible assets: 300916000
Owner earnings: 11839000
Return on net tangible assets (%): 3.9343205412806235
Capex to operating income (%): 9.346534653465346
Buffett classification: The Great
Stock price: 10.48
P/E ratio: 23.83606259470417
Shares outstanding: 71808413
Book value: 440803000
P/B ratio: 1.7072301419001232
Market cap (USD): 752552168.24
Debt to equity: 1.5397830777013768
Current ratio: 1.789491431591132
Quick ratio: 1.789491431591132
COGS to revenue (%): 59.101745995811875
R&D to revenue (%): 6.87786518761673
SG&A to revenue (%): 19.72982341954836
Free cash flow (dilution-adjusted): 17479000
Buyback yield (%): 0
Retained earnings: -936150000
Receivables turnover: 2.294582200397711
Capitalized R&D asset: 19444000
ROCI (R&D-adjusted, %): 4.855062046945691
FCF margin (%): 6.18279189541004
Rule of 40 score: 6.18279189541004
Financial ratios for PGY — quarterly report dated 2025-06-30
Total revenue: 317714000
Gross profit: 126249000
Operating income: 47785000
Net income: 16655000
Capital expenditures: 3800000
Operating cash flow: 57350000
Depreciation & amortization: 7593000
Net tangible assets: 333328000
Owner earnings: 20448000
Return on net tangible assets (%): 6.134498151970432
Capex to operating income (%): 7.952286282306163
Buffett classification: The Great
Stock price: 21.32
P/E ratio: 62.36578805442398
Shares outstanding: 71808413
Book value: 467979000
P/B ratio: 3.2714189422174926
Market cap (USD): 1530955365.16
Debt to equity: 1.6319407494780749
Current ratio: 1.42440651856975
Quick ratio: 1.42440651856975
Effective tax rate (%): 23.109419247017314
COGS to revenue (%): 60.26331858212103
R&D to revenue (%): 5.808683281190001
SG&A to revenue (%): 18.887741805523206
Free cash flow (dilution-adjusted): 35322000
Buyback yield (%): 0
Retained earnings: -919495000
Receivables turnover: 2.4845669599217985
Capitalized R&D asset: 31482480
ROCI (R&D-adjusted, %): 4.558214953128623
Rosenberg metric: 0.5465953507508743
FCF margin (%): 11.11754596901616
Revenue growth (%): 12.383977587865754
Rule of 40 score: 23.501523556881914
Financial ratios for PGY — quarterly report dated 2025-09-30
Total revenue: 339887000
Gross profit: 139313000
Operating income: 69680000
Net income: 23273000
Capital expenditures: 3240000
Operating cash flow: 67046000
Depreciation & amortization: 7636000
Net tangible assets: 406301000
Owner earnings: 27669000
Return on net tangible assets (%): 6.809975855338776
Capex to operating income (%): 4.649827784156142
Buffett classification: The Great
Stock price: 29.69
P/E ratio: 44.58275197026411
Shares outstanding: 71808413
Book value: 535835000
P/B ratio: 3.978821431914675
Market cap (USD): 2131991781.97
Debt to equity: 1.4975132270195115
Current ratio: 2.310418248296203
Quick ratio: 2.310418248296203
Effective tax rate (%): -188.63946421927324
COGS to revenue (%): 59.01196574155529
R&D to revenue (%): 5.365312589184052
SG&A to revenue (%): 15.12179047742338
Free cash flow (dilution-adjusted): 50224000
Buyback yield (%): 0
Retained earnings: -896950000
Capitalized R&D asset: 37017370
ROCI (R&D-adjusted, %): 5.022827381475343
Rosenberg metric: 0.7078840422649688
FCF margin (%): 14.776675777537829
Revenue growth (%): 6.978918146509125
Rule of 40 score: 21.755593924046956
Financial ratios for PGY — annual report dated 2025-12-31
Total revenue: 1261341000
Gross profit: 512172000
Operating income: 223808000
Net income: 81389000
Capital expenditures: 13902000
Operating cash flow: 238620000
Depreciation & amortization: 30077000
Net tangible assets: 449453000
Owner earnings: 97564000
Return on net tangible assets (%): 21.707275287961146
Capex to operating income (%): 6.211574206462682
Buffett classification: The Great
Stock price: 20.9
P/E ratio: 18.439787092850384
Shares outstanding: 71808413
Book value: 555351000
P/B ratio: 2.702427530876869
Market cap (USD): 1500795831.6999998
Debt to equity: 1.545840378427337
Current ratio: 11.064169170501655
Quick ratio: 11.064169170501655
Effective tax rate (%): -38.24697336561743
COGS to revenue (%): 59.394644271453956
R&D to revenue (%): 5.962939443021356
SG&A to revenue (%): 16.898760921907716
Free cash flow (dilution-adjusted): 170600000
Buyback yield (%): 0
Retained earnings: -862654000
Receivables turnover: 6.4417235250857985
Capitalized R&D asset: 151061960
ROCI (R&D-adjusted, %): 14.28492075200802
Rosenberg metric: 1.3748547100077053
FCF margin (%): 13.525287769128253
Revenue growth (%): 25.562789308645662
Rule of 40 score: 39.08807707777392
Financial ratios for PGY — quarterly report dated 2025-12-31
Total revenue: 321036000
Gross profit: 130989000
Operating income: 65943000
Net income: 34296000
Capital expenditures: 3086000
Operating cash flow: 79797000
Depreciation & amortization: 7126000
Net tangible assets: 449453000
Owner earnings: 38336000
Return on net tangible assets (%): 8.52947916689843
Capex to operating income (%): 4.67979922053895
Buffett classification: The Great
Stock price: 20.9
P/E ratio: 18.276311015989382
Shares outstanding: 71808413
Book value: 555351000
P/B ratio: 2.702427530876869
Market cap (USD): 1500795831.6999998
Debt to equity: 1.545840378427337
Current ratio: 11.064169170501655
Quick ratio: 11.064169170501655
Effective tax rate (%): -31.596356880692372
COGS to revenue (%): 59.1980338653609
R&D to revenue (%): 5.942635716866644
SG&A to revenue (%): 14.318643392018341
Free cash flow (dilution-adjusted): 67575000
Buyback yield (%): 0
Retained earnings: -862654000
Receivables turnover: 1.639544860271286
Capitalized R&D asset: 37386270
ROCI (R&D-adjusted, %): 4.575679810653266
Rosenberg metric: -0.4564597499451634
FCF margin (%): 21.049041229021046
Revenue growth (%): -5.546255078893868
Rule of 40 score: 15.502786150127179
Financial ratios for PMN — annual report dated 2021-12-31
Capital expenditures: 72670.07874015748
Depreciation & amortization: 36082.67716535433
Buffett classification: The Gruesome
Stock price: 165
Shares outstanding: 8967693
Market cap (USD): 1479669345
Buyback yield (%): 0.08747019393507076
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PMN — annual report dated 2022-12-31
Total revenue: 0
Operating income: -17191111.76470588
Net income: -13281075.735294117
Capital expenditures: 1456.6176470588234
Operating cash flow: -12524913.970588235
Depreciation & amortization: 8247.05882352941
Net tangible assets: -1006330.8823529411
Owner earnings: -13274285.294117646
Buffett classification: The Gruesome
Stock price: 108.5
Shares outstanding: 8967693
Book value: -991008.8235294111
Market cap (USD): 972994690.5
Debt to equity: 0
Current ratio: 1.0764758514053543
Quick ratio: 1.0764758514053543
Interest coverage ratio: -82.88867774689433
Free cash flow (dilution-adjusted): -12884922.058823528
Buyback yield (%): 0
Retained earnings: -59009899.99999999
Receivables turnover: 0
Capitalized R&D asset: 11828800
ROCI (R&D-adjusted, %): -76.24139218347705
Rule of 40 score: 0
Financial ratios for PMN — annual report dated 2023-12-31
Total revenue: 0
Operating income: -10805100.757575758
Net income: -10009456.06060606
Capital expenditures: 0
Operating cash flow: -8214906.060606061
Depreciation & amortization: 16029.545454545454
Net tangible assets: 2843406.0606060605
Owner earnings: -9993426.515151516
Return on net tangible assets (%): -351.45970368444165
Buffett classification: The Gruesome
Stock price: 28.75
Shares outstanding: 8967693
Book value: 2843406.0606060596
P/B ratio: 90.6733573238029
Market cap (USD): 257821173.75
Debt to equity: 0
Current ratio: 1.456645705481118
Quick ratio: 1.456645705481118
Interest coverage ratio: -70.82145588162273
Free cash flow (dilution-adjusted): -8420619.696969697
Buyback yield (%): 0
Retained earnings: -70807534.84848484
Receivables turnover: 0
Capitalized R&D asset: 13897390.696969697
ROCI (R&D-adjusted, %): -62.84574746967917
Rule of 40 score: 0
Financial ratios for PMN — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 31.25
Shares outstanding: 8967693
Market cap (USD): 280240406.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PMN — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 23.75
Shares outstanding: 8967693
Market cap (USD): 212982708.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PMN — annual report dated 2024-12-31
Total revenue: 0
Operating income: -11767467.132867133
Net income: 1943267.8321678322
Capital expenditures: 0
Operating cash flow: -19008458.04195804
Depreciation & amortization: 0
Net tangible assets: 11530193.006993007
Owner earnings: 1943267.8321678322
Return on net tangible assets (%): 16.853732031972488
Buffett classification: The Gruesome
Stock price: 23.75
P/E ratio: 109.6002852640261
Shares outstanding: 8967693
Book value: 11530193.006993009
P/B ratio: 18.471738384676385
Market cap (USD): 212982708.75
Debt to equity: 0
Current ratio: 8.524721818407203
Quick ratio: 8.524721818407203
Interest coverage ratio: -219.17913383262783
Free cash flow (dilution-adjusted): -19585946.153846152
Buyback yield (%): 0
Retained earnings: -63417533.56643357
Receivables turnover: 0
Capitalized R&D asset: 15343951.502913753
ROCI (R&D-adjusted, %): -47.160975680850555
Rule of 40 score: 0
Financial ratios for PMN — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -5216849.6503496505
Net income: -5138393.706293707
Capital expenditures: 0
Operating cash flow: -3445360.839160839
Net tangible assets: 6623588.1118881125
Owner earnings: -5138393.706293707
Return on net tangible assets (%): -77.57719259552451
Buffett classification: The Gruesome
Stock price: 17.5
Shares outstanding: 8967693
Book value: 6623588.1118881125
P/B ratio: 23.6932950613779
Market cap (USD): 156934627.5
Debt to equity: 0
Current ratio: 3.3643581457544016
Quick ratio: 3.3643581457544016
Free cash flow (dilution-adjusted): -3616895.804195804
Buyback yield (%): 0
Retained earnings: -68555927.27272728
Receivables turnover: 0
Capitalized R&D asset: 3821153.8461538465
ROCI (R&D-adjusted, %): -25.355991901429313
Rule of 40 score: 0